Factors Influencing Hemoglobin Variability and Its Association With Mortality in Hemodialysis Patients
Baskent University Nephrology Department
1 other identifier
observational
169
0 countries
N/A
Brief Summary
The aim of the study is to investigate the factors influencing hemoglobin variability with inflammatory and nutritional parameters and its associations with all-cause mortality among hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2009
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2010
CompletedFirst Submitted
Initial submission to the registry
February 2, 2018
CompletedFirst Posted
Study publicly available on registry
March 6, 2018
CompletedMarch 6, 2018
February 1, 2018
1 year
February 2, 2018
February 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients
investigation of factors influencing hemoglobin variability with inflammatory and nutritional parameters and the association of hemoglobin variability with all-cause mortality among hemodialysis patients
six month
Study Arms (6)
L Hemoglobin
L Hemoglobin: consistently low all 6 months with low hemoglobin levels
T Hemoglobin
T Hemoglobin; consistently within the target range all 6 months with target-range hemoglobin levels
H Hemoglobin
H Hemoglobin: consistently high all 6 months with high hemoglobin levels
LAL Hemoglobin
LAL Hemoglobin: low amplitude fluctuation with low hemoglobin; all 6 months with low or target range hemoglobin levels
LAH Hemoglobin
LAH Hemoglobin: low-amplitude fluctuation with high hemoglobin levels 6 months with target-range or high hemoglobin levels)
HA Hemoglobin
HA Hemoglobin ; high-amplitude fluctuation low, target-range, and high hemoglobin levels within the 6 month period
Eligibility Criteria
-one hundred and sixty nine patient that receive chronic hemodialysis treatment in Baskent university hospital were enrolled to the study.
You may qualify if:
- Age \>18
- on chronic hemodialysis treatment
You may not qualify if:
- All patients had a minimum of six hemoglobin measurements within a 6- month period, and they were excluded if they received a kidney transplant during this period or those who had blood transfusions during the baseline period.
- Patients with serum ferritin\<100 μg/L were also excluded from the study because of reimbursement of our country.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Bal Z, Demirci BG, Karakose S, Tutal E, Erkmen Uyar M, Acar NO, Sezer S. Factors Influencing Hemoglobin Variability and Its Association with Mortality in Hemodialysis Patients. ScientificWorldJournal. 2018 Apr 1;2018:8065691. doi: 10.1155/2018/8065691. eCollection 2018.
PMID: 29805324DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Baskent University Nephrology Department
Study Record Dates
First Submitted
February 2, 2018
First Posted
March 6, 2018
Study Start
January 1, 2009
Primary Completion
January 1, 2010
Study Completion
February 1, 2010
Last Updated
March 6, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share